Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Patent Protection
Pharma
Drugmakers dig in their heels amid FTC's latest patent crackdown
Companies that face FTC challenges against their Orange Book listings have opted not to remove any patents.
Angus Liu
Jun 25, 2024 9:20am
FTC targets Novo's Ozempic among 300-plus 'junk' patents
May 1, 2024 7:30am
Lawmakers blast Biden administration's 'march-in' proposal
Feb 23, 2024 9:53am
FTC calls for 'expansive and flexible' use of march-in rights
Feb 6, 2024 5:00pm
US lawmakers push for answers on insulin prices, patent reform
Aug 31, 2023 3:17pm
Roche takes Biogen to court over royalties for Tysabri
Mar 1, 2023 5:10pm
